prednisolone acetate has been researched along with Pseudotumor Cerebri in 1 studies
prednisolone acetate: RN given refers to cpd with locant for acetate group in position 21 & (11 beta)-isomer
Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curragh, D | 1 |
| McLoone, E | 1 |
1 other study available for prednisolone acetate and Pseudotumor Cerebri
| Article | Year |
|---|---|
Pseudotumour Cerebri Syndrome in Two Children on Systemic Steroid Therapy for Uveitis.
Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Female; Humans; Male; Prednisolone; Pseudotumor C | 2018 |